Followers | 246 |
Posts | 49775 |
Boards Moderated | 63 |
Alias Born | 08/29/2007 |
Sunday, March 17, 2024 12:40:24 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent LTRN News
- Lantern Pharma to Report First Quarter 2024 Operating & Financial Results on May 9th, 2024 at 4:30 p.m. ET • Business Wire • 05/02/2024 11:30:00 AM
- Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development • Business Wire • 04/24/2024 12:00:00 PM
- Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan • Business Wire • 04/22/2024 12:12:00 PM
- Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights • Business Wire • 03/18/2024 08:02:00 PM
- Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks • IH Market News • 03/18/2024 11:12:12 AM
- Lantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284 • Business Wire • 03/15/2024 12:00:00 PM
- Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET • Business Wire • 03/11/2024 11:30:00 AM
- Lantern To Participate in H.C Wainwright & Co.’s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference • Business Wire • 03/05/2024 01:01:00 PM
- Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines • Business Wire • 03/04/2024 01:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:54:06 AM
- Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers • Business Wire • 02/15/2024 01:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:30:18 PM
- Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer • Business Wire • 01/17/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:05:36 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/01/2023 11:02:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 11:00:35 AM
- FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL) • Business Wire • 11/30/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:05:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:05:29 PM
- Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights • Business Wire • 11/08/2023 09:01:00 PM
- Lantern Pharma to Report Third Quarter 2023 Operating & Financial Results on November 8th, 2023 at 4:30 p.m. ET • Business Wire • 11/01/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 09:25:40 PM
- Lantern Pharma to Present at the ThinkEquity Conference on October 19 at 1:30 p.m. ET • Business Wire • 10/10/2023 12:00:00 PM
- Lantern Pharma Announces Publication in Clinical Cancer Research Highlighting the Enhanced Efficacy of LP-184 in Glioblastoma • Business Wire • 10/03/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM